Nasdaq closes above 20,000 points for the first time
The tech-heavy index gained 1.8 percent after November’s inflation report matched expectations from economists.
Stock Market Today: Nasdaq Looks To Close Above 20,000 As Alphabet, Apple Hit New Highs; Dow Jones Drags Its Feet (Live Coverage)
The Dow Jones crept up flat while the S&P 500 rose after CPI data. Google parent Alphabet stock climbed to a record high on ...
Super Micro Stock Falls. CEO Fails to Reassure Market About SMCI’s Nasdaq Future.
Super Micro Computer stock was falling early Wednesday after the CEO’s attempts to ease concerns about the stock failed to ...
Stock market today: Dow, S&P 500, Nasdaq fall as investors await key inflation data
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.IM06wodO.js ...
Indian stock market: 7 key things that changed for market overnight - Gift Nifty, US inflation to Nasdaq at record high
Gift Nifty was trading around 24,750 level, a premium of nearly 15 points from the Nifty futures’ previous close, indicating a muted start for the Indian stock market indices.
Palantir Stock, MicroStrategy Could Join the Nasdaq 100. Which Ones Might Exit.
Palantir Technologies leads the list of a half dozen companies that could be added to the $26 trillion Nasdaq 100 index at ...
Nasdaq3d
Stocks Finish Mostly Higher on Positive US Economic News
Stocks on Friday settled mixed, with the S&P 500 and Nasdaq 100 posting new record highs. Friday’s US Nov payrolls report supported the broader market as the report boosted expectations for ...
Dow ends lower, S&P 500, Nasdaq pull back from record highs as Nvidia loses ground
Major U.S. stock averages fell Monday, with market behemoth Nvidia (NVDA) emerging as a source of downward pressure after ...
Nasdaq hits 20,000 as inflation data raises Dec rate-cut hopes
The Nasdaq crossed 20,000 points for the first time on Wednesday, as tech stocks rallied after the latest inflation report ...
3 Momentum Stocks Soaring Into 2025 and Beyond
Investors considering Monopar should keep a close eye out for announcements about further development of ALXN-1840. Any updates on its MNPR-101 line of oncology products, all of which are either in ...